RUNX3 and hepatocellular carcinoma: Thus, based on the structure of existing Tet-CD147CAR, super CAR-T cells that express chemokine receptors such as CCR5 and transcription factor RUNX3 in tandem are expected to demonstrate better long-term therapeutic effects against HCC.